跳转至内容
Merck
CN

V6633

VEGF Receptor-3 (Flt-4)/Fc Chimera from mouse

>95% (SDS-PAGE), recombinant, expressed in baculovirus infected Sf21 cells, lyophilized powder

别名:

Vascular Endothelial Growth Factor Receptor‑3

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

UNSPSC Code:
12352202
MDL number:
Biological source:
mouse
Recombinant:
expressed in baculovirus infected Sf21 cells
Assay:
>95% (SDS-PAGE)
Form:
lyophilized powder
Mol wt:
110-120 kDa by SDS-PAGE (glycosylation), calculated mol wt ~84.5 kDa
Impurities:
endotoxin, tested
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

biological source

mouse

recombinant

expressed in baculovirus infected Sf21 cells

assay

>95% (SDS-PAGE)

form

lyophilized powder

mol wt

110-120 kDa by SDS-PAGE (glycosylation), calculated mol wt ~84.5 kDa

packaging

pkg of 1 mg

storage condition

avoid repeated freeze/thaw cycles (Do not store in a frost-free freezer.)

impurities

endotoxin, tested

UniProt accession no.

storage temp.

−20°C

Gene Information

mouse ... Flt4(14257)

Application

VEGF Receptor-3 (Flt-4)/Fc Chimera from mouse is a disulfide-linked homodimeric protein consist of VEGF Receptor-3 fused with6X histidine tagged Fc portion of human IgG1 by a polypeptide linker. It may be used as a specific marker for lymphatic vessels as well as plays a pivotal role in the development of the lymphatic vessel system. The product was used to study the novel technique for pharmacological manipulation of blood and lymphatic vascularization in cultured mouse embryos ex vivo.

Biochem/physiol Actions

VEGF Receptor-3 (Flt-4) belongs to class III subfamily of RTKs and is expressed mainly in endothelial cells. VEGF Receptor-3 can block VEGF-C/D and inhibits lymphangiogenesis and lymphatic metastasis in orthotopic urinary bladder cancer (OUBC).

Physical form

Lyophilized from a 0.2 μm filtered solution in phosphate buffered saline

Analysis Note

The activity is measured by its ability to bind human VEGF-D.

存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

法规信息

新产品

此项目有


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Ayako Fujiwara et al.
Lung cancer (Amsterdam, Netherlands), 106, 8-16 (2017-03-14)
Epithelial to mesenchymal transition (EMT) relates to both organ fibrosis and malignant behavior of cancer. Pirfenidone (PFD) is an anti-fibrotic agent for idiopathic pulmonary fibrosis and one of its functions may be to inhibit fibrotic EMT. This study aimed to
Hanseul Yang et al.
Molecular cancer, 10, 36-36 (2011-04-13)
Most bladder cancer patients experience lymphatic metastasis in the course of disease progression, yet the relationship between lymphangiogenesis and lymphatic metastasis is not well known. The aim of this study is to elucidate underlying mechanisms of how expanded lymphatic vessels
Martin Zeeb et al.
Nature protocols, 7(11), 1970-1982 (2012-10-13)
Formation of new blood and lymphatic vessels is involved in many physiological and pathological processes, including organ and tumor growth, cancer cell metastasis, fluid drainage and lymphedema. Therefore, the ability to manipulate vascularization in a mammalian system is of particular

相关内容

全球贸易项目编号

货号GTIN
V6633-.1MG04061832277837

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持